Actavis Group announces business alliance and joint venture in with a Japanese generic pharmaceutical producer

Actavis announced a preliminary agreement with ASKA Pharmaceutical concerning the establishment of a joint company: Actavis ASKA Co., Ltd. - planning to enter the Japanese generic pharmaceutical market in April 2009. Actavis will hold 45% of shares in the joint venture; ASKA 55% Strategic Rationale Japanese government policy requires an increase in the ... Read More...